A string of firms including Slaughter and May and Cravath, Swaine & Moore are acting on Johnson & Johnson’s $30bn offer to buy Swiss biotech company Actelion.
Slaughters, Niederer Kraft & Frey and Wachtell Lipton Rosen & Katz represented Actelion, while Cravath, Swaine & Moore, Homburger and Sexton Riley are acting as legal advisers to Johnson & Johnson. Cravath’s team was led by partners Robert Townsend and Damien Zoubek.
Your limit of 1 article in 30 days is up. Please login for full access or subscribe.
Corporate users - click here for simple access (no password needed).
For more information, please contact [email protected]
